A

Nutcracker syndrome (a Delphi consensus)

Journal of Vascular Surgery Venous and Lymphatic Disorders, vol. 13, pp. 101970

Abstract

BACKGROUND: Nutcracker syndrome (NCS) describes the symptomatic compression of the left renal vein between the aorta and superior mesenteric artery. Whereas asymptomatic compression is a common radiological finding, patients with NCS can report a range of symptoms. There are no specific diagnostic criteria and interventions include a range of open surgical and endovascular procedures. Therefore, we wished to develop an international consensus document covering aspects of diagnosis, management, and follow-up for patients with NCS. METHODS: A three-stage modified Delphi consensus was performed. A steering committee developed 37 statements covering 3 categories for patients with NCS: diagnosis, management, and follow-up. These statements were reported individually by 20 international experts in the management of venous disease, using a 5-point Likert scale. Consensus was defined if ≥70% of respondents rated the statement between 1 and 2 (agreement) and between 4 and 5 (disagreement). Those statements without consensus were recirculated in a second round of voting. A third round of the questionnaire was performed with 14 additional statements to clarify diagnostic values of NCS. RESULTS: Responses were returned by 20 of 20 experts (100%) in round one and 17 of 20 (85%) in round two. Initial consensus was reached in 24 of 37 statements (65%) spread over all categories. Round two achieved a further consensus on 5 out of 10 statements (50%). No categories reported consensus on all statements. In round two consensus was reached in the category of follow-up (4/5 statements [80%]). The final round reached consensus on 5 out of 14 statements (36%). Experts agreed that imaging is obligated to confirm NCS. Experts did not agree on specific diagnostic cut-off values. There was a consensus that the first choice of operative treatment is left renal vein transposition and that the risk of stent migration outweighs the advantages of a percutaneous procedure. CONCLUSIONS: Consensus was achieved on most statements concerning the assessment and management of NCS. This Delphi consensus identified those areas in which further research is needed, such as antiplatelet therapy, endovascular treatment, and renal autotransplantation. A rare disease registry to improve data and reports of patient outcomes is warranted.

Authors 21

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Vascular Surgery, Leiden University Medical Center, Leiden, the Netherlands

  2. Mayo Clinic

    Affiliation as printed

    Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN

  3. University Hospital Galway

    Affiliation as printed

    Department of Interventional Radiology, Galway University Hospital, Galway, Ireland

  4. Affiliation as printed

    Department of Vascular Surgery, Clinique Générale, Annecy, France

  5. National and Kapodistrian University of Athens · Athens Medical Center

    Affiliation as printed

    Department of Vascular Surgery, Athens Medical Center, University of Athens, Athens, Greece

  6. University Hospitals of Cleveland · University Hospitals Cleveland Medical Center · Case Western Reserve University

    Affiliation as printed

    Department of Vascular Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve, Cleveland, OH

  7. Ashtead Hospital

    Affiliation as printed

    Department of Vascular Surgery, Ashtead Hospital, Ashtead, UK

  8. Mayo Clinic · Mayo Clinic in Florida

    Affiliation as printed

    Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL

  9. Leiden University Medical Center

    Affiliation as printed

    Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands

  10. University of East London · Monash University

    Affiliation as printed

    Department of Anesthesia and Perioperative Medicine, Monash University, Melbourne, Victoria, Australia; Department of Surgery, School of Health, Sport & Bioscience University of East London, London, UK

  11. University College London

    Affiliation as printed

    Institute of Clinic Trials and Methodology, University College London, London, UK

  12. Wollongong Hospital

    Affiliation as printed

    Department of Vascular Surgery, Wollongong Hospital, Wollongong, New South Wales, Australia

  13. Affiliation as printed

    Department of Vascular Surgery, The Rane Center for Venous and Lymphatic Disorders, Jackson, MS

  14. University of Colorado Anschutz

    Affiliation as printed

    Department of Vascular Surgery, University of Colorado Anschutz Medical Center, Aurora, CO

  15. The University of Queensland

    Affiliation as printed

    Department of Vascular Surgery, University of Queensland, Brisbane, Queensland, Australia

  16. Harvard University · Massachusetts General Hospital

    Affiliation as printed

    Department of Vascular Surgery, Massachusetts General Hospital and Harvard University, Boston, MA

  17. Affiliation as printed

    Department of Vascular Surgery, Atrium Health Sanger Heart and Vascular Institute, Charlotte, NC

  18. Université de Franche-Comté

    Affiliation as printed

    Department of Vascular and Endovascular Surgery, University of Franche Comté, Besançon, France

  19. Washington University in St. Louis · Washington University Medical Center

    Affiliation as printed

    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO

  20. Leiden University Medical Center

    Affiliation as printed

    Department of Vascular Surgery, Leiden University Medical Center, Leiden, the Netherlands

  21. Leiden University Medical Center

    Affiliation as printed

    Department of Vascular Surgery, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.r.van_der_vorst@lumc.nl

Cited by 27 stored of 28

No patents citing this paper on Lens.org (checked 2026-10-11).

References 28